, Singapore

Daily Markets Briefing: STI up 0.12%

Brace for a pullback today.

According to OCBC, while continued gains on Wall Street overnight could keep local sentiment fairly upbeat, the STI could be hard pressed to chalk up further gains, especially after the smart 8.8% rebound since Brexit.

Here’s more from OCBC:

Besides a still-weak fundamental picture (Jun NODX fell 2.3%), we believe that any earnings disappointment could provide a convenient excuse to take profit; local banks are due to report 2Q earnings around end Jul. 

Technically, we note that the recent price action may have also formed a potential reversal signal; daily RSI is now just shy of the overbought region, while MACD is starting to turn down. 

For now, we peg the key hurdle at 2990-3000 region; key support at 2900. Overall volume slipped 20% yesterday; total value was down 18%; average value/unit was flat at S$0.55.

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
Shipping & Marine
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare